Evidence map›Paper›PMID 42060813›Full record

ArticleIndian journal of pharmacology2026

Tapentadol-induced urticarial rash in a patient with acute pancreatitis.

Srinu Deshidi, Vinod Hanumanthu, Gaurav Mahajan, Sreekanth Appasani

Abstract readCase Reports
In one paragraph

Article in Indian journal of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Srinu DeshidiDepartment of Gastroenterology, Krishna Institute of Medical Sciences, Secunderabad, Telangana, India.
Vinod HanumanthuDepartment of Dermatology, NRI Institute of Medical Sciences, Vishakhapatnam, Andhra Pradesh, India.
Gaurav MahajanDepartment of Gastroenterology, Indian Naval Hospital Ship (INHS) Asvini, Mumbai, Maharashtra, India.
Sreekanth AppasaniDepartment of Gastroenterology, Krishna Institute of Medical Sciences, Secunderabad, Telangana, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractTapentadol, a dual-action opioid, is increasingly used for pain management in acute pancreatitis (AP). Although its common side effects are well-documented, cutaneous reactions are rare. We report a 30-year-old gentleman with AP who developed generalized urticaria following oral tapentadol use. The patient had no prior history of atopy or drug allergies. The rash resolved after discontinuation of tapentadol and administration of a short course of corticosteroids and antihistamines. Cutaneous reactions to tapentadol are extremely rare but should be recognized promptly to ensure timely management and prevent unnecessary investigations.

Indexed as

Analgesics, OpioidPancreatitisPhenolsUrticariaAcute DiseaseAdultHumansMaleTapentadolAnalgesics, OpioidPhenolsTapentadolAbdominal painacute pancreatitistapentadolurticaria

Identifiers

PMID42060813
PMCPMC13258342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.